Shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Stock Performance
The company has a market cap of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The stock’s fifty day simple moving average is $22.00 and its two-hundred day simple moving average is $22.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Articles
- Five stocks we like better than H. Lundbeck A/S
- How to Read Stock Charts for Beginners
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Most active stocks: Dollar volume vs share volume
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- EV Stocks and How to Profit from Them
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
